LRRC69 (leucine rich repeat containing 69) is a testis-specific gene involved in spermatogenic function and intracellular signal transduction. A novel recurrent intragenic deletion in LRRC69 was significantly overrepresented in men with spermatogenic failure (SPGF), occurring in 3.3% of SPGF patients versus 0.85% in the general population (OR = 3.9, P = 0.0001) 1. This deletion is associated with oligozoospermia and reduced testicular volume in affected individuals 1. At the molecular level, LRRC69 is implicated in spermiogenesis regulation, with proteomic studies demonstrating that LRRC69 abundance changes in response to glycoprotein hormone signaling during late spermatid development 2. Beyond reproductive function, LRRC69 has been identified as a key prognostic gene associated with colorectal cancer progression, showing significant correlation with survival outcomes at 1-, 3-, and 5-year timepoints 3. Clinically, LRRC69 deletion screening in infertile men may improve reproductive health management and genetic counseling, while its role in CRC progression suggests potential as a biomarker for cancer risk stratification and therapeutic targeting.